Outset Medical, Inc. (OM)
Nasdaq: OM · Electromedical & Electrotherapeutic Apparatus · San Jose, CA · filing with the SEC since 2010
Who owns Outset Medical, Inc.
As filed with the SECHolders of 5% or more
4
BML Investment Partners, L.P. holds 14.7% of Common Stock, par value $0.001 per share, as its SCHEDULE 13G/A filed Oct 6, 2026 says.
Directors and officers
11
report now, of 34 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
BML Investment Partners, L.P.
SCHEDULE 13G/A · filed Oct 6, 2026 · Common Stock, par value $0.001 per share · 13.6% in May 18, 2026
Fmr LLC
SCHEDULE 13G/A · filed Apr 7, 2025 · COMMON STOCK · 7% in Feb 12, 2025
Perceptive Advisors LLC
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock, $0.001 par value per share · 9.5% in Feb 28, 2025
AQR Capital Management, LLC
SCHEDULE 13G · filed Aug 12, 2026 · Common Stock, par value $0.001 per share
Bank of America Corporation
SCHEDULE 13G/A · filed Aug 12, 2026 · Common Stock · reported falling below 5%, from 5.2% in Feb 11, 2026
PFM Health Sciences, LP
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, par $0.001 per share (the "Shares") · reported falling below 5%, from 9.4% in Mar 17, 2025
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 29, 2026 · Common Stock · reported falling below 5%, from 6.8% in Oct 17, 2025
Woodline Partners LP
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 7.5% in May 15, 2025
Alyeska Investment Group, L.P.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 9.61% in May 15, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 5.59% in Jul 29, 2025
Durable Capital Partners LP
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, par value of $0.001 per share · reported falling below 5%, from 7.6% in Nov 14, 2025
T. Rowe Price Investment Management, Inc.
SCHEDULE 13G/A · filed Nov 14, 2025 · COMMON STOCK · reported falling below 5%, from 8.9% in May 14, 2025
What OM reports owning in othersstakes of 5% or more, and other ties
Outset Medical, Inc. reports no stake in another company in the record.
Insider tradesForm 4
23sales
0purchases
0sales on a scheduled plan
5people selling
$400,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 5, 2025 to Oct 5, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 5, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window6 of 37 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Trigg Leslie | Chair and CEO | 7 | $100,000 | 0 | 0 | $0 |
| Gaeta Renee | Chief Financial Officer | 2 | $100,000 | 0 | 0 | $0 |
| Brottem John L. | General Counsel | 7 | $100,000 | 0 | 0 | $0 |
| Leonard Braden Michael | 10% owner | 0 | $0 | 0 | 2 | $900,000 |
| Nash Marc | EVP Operations R&D & Service | 6 | $0 | 0 | 0 | $0 |
| Drexler Karen | director | 1 | $0 | 0 | 0 | $0 |